|
Jul 25
|
Alkermes' (ALKS) Q2 Earnings Miss Estimates, Revenues Beat
|
|
Jul 24
|
Alkermes (ALKS) Reports Q2 Earnings: What Key Metrics Have to Say
|
|
Jul 24
|
Alkermes (ALKS) Lags Q2 Earnings Estimates
|
|
Jul 24
|
Is Alkermes plc's (NASDAQ:ALKS) Latest Stock Performance Being Led By Its Strong Fundamentals?
|
|
Jul 24
|
Alkermes plc Reports Second Quarter 2024 Financial Results
|
|
Jun 24
|
Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar?
|
|
Jun 3
|
Alkermes Presents Data From Phase 1b Study of ALKS 2680 Demonstrating Improved Wakefulness in Patients With Narcolepsy Type 1 at SLEEP 2024
|
|
May 31
|
Why Is Alkermes (ALKS) Down 2.7% Since Last Earnings Report?
|
|
May 29
|
Alkermes to Participate in Two Upcoming Investor Conferences
|
|
May 28
|
Alkermes to Present New Clinical Data for ALKS 2680 at SLEEP 2024
|
|
May 25
|
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
|
|
May 21
|
Do Options Traders Know Something About Alkermes (ALKS) Stock We Don't?
|
|
May 14
|
Alkermes Highlights Data Presentations Related to its Psychiatry Franchise at Spring 2024 Scientific Conferences
|
|
May 2
|
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
|
|
May 2
|
Alkermes plc Completes Sale of Athlone, Ireland Facility to Novo Nordisk
|
|
May 1
|
Alkermes (ALKS) Reports Q1 Earnings: What Key Metrics Have to Say
|
|
May 1
|
Alkermes (ALKS) Q1 Earnings and Revenues Miss Estimates
|
|
May 1
|
Alkermes plc Reports First Quarter 2024 Financial Results
|
|
Apr 30
|
How To Trade Biotech Stocks: Can These Three Tips Help You Make More Profits?
|
|
Apr 24
|
Deciphera Pharmaceuticals, Inc. (DCPH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|